Conditions: Conjunctivitis, Allergic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 236
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the dose response, and efficacy of Mapracorat ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs associated with allergic conjunctivitis using a conjunctival allergen challenge (CAC) model.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Mapracorat intervention 2: Vehicle
Intervention descriptions: intervention 1: administered daily to each eye for 2 weeks following allergen challenge using a CAC model intervention 2: administered daily to each eye for 2 weeks following allergen challenge using a CAC model

Protocol document: